Emphasys Plans 2008 Launch Of Bronchial Valve For Emphysema
This article was originally published in The Gray Sheet
Emphasys Medical is gearing up for a "late 2008" U.S. launch of its Emphasys Bronchial Valve implant for emphysema, funded in part by a proposed initial public stock offering worth up to $86.3 million (see chart: "1Emphasys Medical IPO")
You may also be interested in...
Asking whether FDA’s decision to allow emergency use of two old anti-malarial drugs was ‘political’ misses the point. The issue already was political, and FDA’s action may well be the best way to keep some measure of federal control on supplies of a drug with important other uses.
Guidelines for health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.